FDA Approves Once-Daily Psoriasis Pill
The US Food and Drug Administration (FDA) approved icotrokinra, a first-in-class interleukin-23 receptor antagonist for the treatment of moderate to severe plaque psoriasis in patients aged 12 years or older.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.